Global and gene-specific methylation patterns in cancer: Aspects of tumor biology and clinical potential

Molecular Genetics and Metabolism

Volumn 75, Issue 1, 2002, Pages 1-16

  Frühwald, Michael C ^a   Plass, Christoph ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA (CYTOSINE 5) METHYLTRANSFERASE; GENOMIC DNA;

ANALYTIC METHOD; BRAIN TUMOR; CANCER; CANCER GENETICS; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CHROMATIN STRUCTURE; CPG ISLAND; DNA METHYLATION; DNA REPLICATION; DNA TRANSCRIPTION; FEEDBACK SYSTEM; GENE ACTIVITY; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENE SILENCING; GENETIC STABILITY; GENOME ANALYSIS; GENOME IMPRINTING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SHORT SURVEY;

ARENA;

EID: 0036352687     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2001.3265     Document Type: Article

References (138)

1. The mystique of epigenetics
2. Cancer epigenetics takes center stage
3. Methylation matters
4. The DNA methyltransferases of mammals
5. The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA
6. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
7. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells
8. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer
9. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
10. Transcriptional control at regulatory checkpoints by histone deacetylases: Molecular connections between cancer and chromatin
11. A candidate mammalian DNA methyltransferase related to pmt 1p of fission yeast
12. DNA methyltransferases Dnmt 3a and Dnmt3b are essential for de novo methylation and mammalian development
13. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors
14. A mammalian protein with specific demethylase activity for mCpG DNA
15. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
16. CpNpG methylation in mammalian cells
17. DNA methylation and chromatin modification
18. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
19. Number of CpG islands and genes in human and mouse
20. The sequence of the human genome
21. Initial sequencing and analysis of the human genome
22. CpG islands in vertebrate genomes
23. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells
24. Methylation meets genomics
25. DNA methylation analysis: A review of current methodologies
26. Developmental changes in DNA methylation of the two tobacco pollen nuclei during maturation
27. DNA methylation differences associated with tumor tissues identified by genome scanning analysis
28. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification
29. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors
30. Methylation profiling of CpG islands in human breast cancer cells
31. Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis
32. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from RLGS gels
33. Gene amplification in PNETs/medulloblastomas: Mapping of a novel amplified gene within the MYCN amplicon
34. Use of restriction enzymes to detect potential gene sequences in mammalian DNA
35. High sensitivity mapping of methylated cytosines
36. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
37. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)
38. COBRA: A sensitive and quantitative DNA methylation assay
39. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids
40. Analyses of the genomic methylation status of the human cyclin A1 promoter by a novel real-time PCR-based methodology
41. Cytosine methylation and mammalian development
42. Epigenetic programming of differential gene expression in development and evolution
43. Cytosine methylation and the ecology of intragenomic parasites
44. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
45. Aging and DNA methylation in colorectal mucosa and cancer
46. Imprinting mechanisms
47. DNA methylation and imprinting: Why bother?
48. Epigenetic instability in ES cells and cloned mice
49. Regulation of X-chromosome inactivation in development in mice and humans
50. X chromosome inactivation is mediated by Xist RNA stabilization
51. X-chromosome inactivation: Counting, choice and initiation
52. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation
53. The hallmarks of cancer
54. How many mutations are required for tumorigenesis? Implications from human cancer data
55. Cancer epigenetics comes of age
56. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
57. Complete and tissue-independent methylation of CpG sites in the p53 gene: Implications for mutations in human cancers
58. Cytosine methylation determines hot spots of DNA damage in the human P53 gene
59. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases
60. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers
61. 5-Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinomas which result
62. Reduced genomic 5-methylcytosine content in human colonic neoplasia
63. Hypomethylation of CCGG sites in the 3′ region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer
64. Studies on the hypomethylation of c-myc, c-Ha-ras oncogenes and histopathological changes in human gastric carcinoma
65. Patterns of methylation of the c-myc gene in human colorectal cancer progression
66. DNA hypomethylation and cancer
67. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice
68. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues
69. Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing
70. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
71. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene
72. Whole-genome methylation scan in ICF syndrome: Hypo-methylation of non-satellite DNA repeats D4Z4 and NBL2
73. Genomic imprinting: Implications for human disease
74. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction
75. Wilms tumor genetics
76. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis
77. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
78. From the cover: Loss of imprinting of the insulin-like growth factor II gene occurs by bial-lelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer
79. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies
80. Aberrant promoter methylation of npreviously unidentified methylation targets is a common abnormality in medulloblastomas - Implications for tumor biology and potential clinical utility
81. Global methylation profiling of lung cancer specimens reveals novel methylated genes
82. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci
83. Active repression of methylated genes by the chromosomal protein MBDI
84. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
85. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
86. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor
87. Landscaping the cancer terrain
88. DNA methylation
89. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
90. A gene hypermethylation profile of human cancer
91. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs
92. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells
93. The Pezcoller lecture: Cancer cell cycles revisited
94. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
95. A silencer element in the retinoblastoma tumor-suppressor gene
96. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive responsive promoters
97. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
98. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
99. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
100. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
101. Knocking the SOCS off a tumor suppressor
102. Predicting lung cancer by detecting aberrant promoter methylation in sputum
103. A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA
104. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: Clinical results and possible mechanisms of action
105. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors
106. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase
107. Inhibition of DNA methyltransferase inhibits DNA replication
108. Cytosine methylation targetted to predetermined sequences
109. Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications
110. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation
111. Hypermethylation of the major chromosomal breakpoint in medulloblastoma
112. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene
113. Inactivation of the HIC-1 tumor suppressor gene in medulloblastoma
114. Concordant methylation of the ER and N33 genes in glioblastoma multiforme
115. 5′ CpG island methylation of p16 is associated with absence of p16 expression in glioblastomas
116. Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas
117. CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas
118. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
119. Promoter hypermethylation - Can this change alone ever designate true tumor suppressor gene function?
120. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription
121. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms
122. Genomic structure and chromosomal mapping of the murine and human mbd1, mbd2, mbd3, and mbd4 genes
123. Methylation-induced repression-belts, braces, and chromatin
124. Transcriptional repression by the methyl-CpG-binding protein MeCP 2 involves a histone deacetylase complex
125. Rapid quantification of DNA methylation by high performance capillary electrophoresis
126. Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA
127. Analysis of modified nucleosides and nucleotide sequence of tRNA
128. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells
129. Quantification of 5-methylcytosine in DNA by the chloroacetaldehyde reaction
130. Chromosome methylation patterns during mammalian preimplantation development
131. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique
132. DNA Methylation analysis using bisulfite treatment and PCR-single-strand conformation polymorphism in colorectal cancer showing microsatellite instability
133. p53 activates expression of Hic-1, a new candidate tumour suppressor gene on 17p13.3
134. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
135. p14ARF deletion and methylation in genetic pathways to glioblastomas
136. Methylation and silencing of the thrombospondin-1 promoter in human cancer
137. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island
138. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers